about
The insertion and transport of anandamide in synthetic lipid membranes are both cholesterol-dependentDirect determination of unbound lipophilic ligands in aqueous solutionsQuantification of brain endocannabinoid levels: methods, interpretations and pitfallsInhibition of monoacylglycerol lipase by troglitazone, N-arachidonoyl dopamine and the irreversible inhibitor JZL184: comparison of two different assays.Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase.Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma.Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation.2-Arachidonoylglycerol (2-AG) membrane transport: history and outlookA catalytically silent FAAH-1 variant drives anandamide transport in neurons.Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence.Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation.Noncompetitive, voltage-dependent NMDA receptor antagonism by hydrophobic anionsThe potential relevance of the endocannabinoid, 2-arachidonoylglycerol, in diffuse large B-cell lymphoma.The interaction of fatty acid amide hydrolase (FAAH) inhibitors with an anandamide carrier protein using (19)F-NMR.Transport of endocannabinoids across the plasma membrane and within the cell.Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?2-(3'-Indolyl)-N-arylthiazole-4-carboxamides: Synthesis and evaluation of antibacterial and anticancer activitiesIs there a temperature-dependent uptake of anandamide into cells?The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway.The 'specific' tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake.Further evidence for the existence of a specific process for the membrane transport of anandamide.Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling.Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrateThe effects of pH, temperature and protein concentration on the in vitro binding of flutamide to human serum albumin.Membrane transport of anandamide through resealed human red blood cell membranes.Quantitative profiling of endocannabinoids in lipoproteins by LC-MS/MS.Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications.Endogenous cannabinoid anandamide inhibits nicotinic acetylcholine receptor function in mouse thalamic synaptosomes.Effect of an unstirred layer on the membrane permeability of anandamide.Human serum albumin: A modulator of cannabinoid drugs.Δ9-Tetrahydrocannabinol Induces Endocannabinoid Accumulation in Mouse Hepatocytes: Antagonism by Fabp1 Gene Ablation.Interaction of artemisinin and its derivatives with human serum albumin studied using spectroscopies and molecular modeling methods.Endocannabinoids and Human Sperm Cells.
P2860
Q21092130-D9B620B9-7F79-4911-AB3A-3122992F4606Q24803322-EBE34C6F-FE81-4E61-838D-DEDD11E7BF3EQ34098167-7E72EB03-5F33-4E1B-BF09-68A665C34DDAQ34442314-80C203FC-D0E1-42B6-915C-015688F5EF80Q34491915-54F8CDEB-E118-494A-AB9A-7651948E07A8Q34563164-95FB8F11-A46B-47AE-B3AD-4FBA12215BD8Q35049157-DA2AEFF9-3E61-40E1-B941-0D96F7A03B64Q35594895-EB745FAA-DEB6-44C4-9568-EADBC5D106FFQ35633097-92851705-1D04-426A-95A2-F6AC91759E68Q35784024-72323B51-A630-472A-A29F-0BC94956FC75Q36036102-1029D978-8AD9-41B0-B106-5F1C9DD238AFQ36573159-228F2685-9A7A-426D-B397-027E6184BAA8Q36575297-BFC89375-0605-4688-A5C9-E0C80C090914Q36910533-E792238B-5464-4CA7-828A-35DD1EFB1D51Q38084704-CD2F86E6-4DF3-4AF4-A748-E31BB8F09DC2Q38707482-588C1D45-6799-483F-9333-33F2B8A42576Q38841653-D32D66CB-A043-4CC1-A5A1-3C73F57B65C0Q38961198-65AD1C33-2716-4E50-83B8-A395B87B8481Q39933047-F7F966CE-7103-4532-A85C-7A357FB9B409Q40166022-C2E15152-B15E-4BE9-915B-3FFFE318331CQ40589014-0DC38EAB-4C21-4B1A-A448-0A1160531F6BQ40620117-26E419C8-10D2-4B19-A2F3-76F4C4562E99Q42034486-AF06FD50-E792-470D-BE3D-9F8994F69FDCQ44969774-557495B1-A67F-4BA4-B63F-18E31A8F87A7Q46522893-609AAE05-EC1C-4965-B18D-6D0302C13150Q46757640-99DC868E-E43E-4D00-87C9-D3097A4C346AQ46799280-FC1A3CCC-00E5-437E-B233-928F9182F17BQ46808737-BAF014DD-18BB-46AA-A935-466A1636FD1BQ46859636-963FDA90-3067-467A-9045-38DA58A0D39AQ47701321-76811032-E826-403D-92C3-B1AEABC4C46EQ50134192-EDDCBF61-D11B-475E-AB63-061A94547575Q51018700-F9B68EC7-C7AE-4072-B833-4988C644F5DFQ55506597-028C75FA-748A-4138-BC5C-E2D8A5142CD5
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Binding of anandamide to bovine serum albumin.
@en
Binding of anandamide to bovine serum albumin.
@nl
type
label
Binding of anandamide to bovine serum albumin.
@en
Binding of anandamide to bovine serum albumin.
@nl
prefLabel
Binding of anandamide to bovine serum albumin.
@en
Binding of anandamide to bovine serum albumin.
@nl
P2860
P1476
Binding of anandamide to bovine serum albumin.
@en
P2093
Inge N Bojesen
P2860
P304
P356
10.1194/JLR.M300170-JLR200
P577
2003-07-01T00:00:00Z